In November 2025, the FDA initiated the removal of the “black box” warning from Hormone Replacement Therapy (HRT). HRT will ...
To alleviate vaginal dyspareunia or dryness, a painful symptom of menopause that causes sexual dysfunction, Yale researchers have created a topical estrogen that eliminates side effects of ...
Estrogen agonists/antagonists are compounds with tissue-selective actions. The pharmacological goal of these compounds is to produce beneficial estrogenic actions in certain tissues (e.g., bone and ...